CanSino Moving Coronavirus Vaccine To Phase III
CanSino plans to start a Phase III study soon for its candidate with a 40,000 enrollment target, discloses its co-founder.
CanSino plans to start a Phase III study soon for its candidate with a 40,000 enrollment target, discloses its co-founder.